fromNatural Health News
3 weeks agoAlternative medicine
Blockbuster Anticlotting Drug Approved on Flawed Studies
Ticagrelor's approval and reputation rest on unreliable trial data and FDA reviewer concerns, raising safety questions and prescribing risks for patients.